BAM
COLL icon

Ballast Asset Management’s Collegium Pharmaceutical COLL Stock Holding History

Ballast Asset Management’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.06M Sell
112,111
-1,112
-1% -$38K 1.62% 32
2026
Q1 		$3.74M Buy
113,223
+2,780
+3% +$118K 1.67% 31
2025
Q4 		$5.11M Sell
110,443
-3,872
-3% -$162K 2.42% 15
2025
Q3 		$4M Buy
114,315
+27,109
+31% +$942K 1.83% 26
2025
Q2 		$2.58M Buy
+87,206
New +$2.49M 1.34% 32

Other funds holding COLL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

Ballast Asset Management's COLL Position: Q2 2026 in Review

Ballast Asset Management reduced its Collegium Pharmaceutical (COLL) stake by 0.98% in Q2 2026, selling an estimated $38K and leaving 112,111 shares worth $4.06M. The position accounts for 1.62% of the portfolio, ranked #32.

Ballast Asset Management first reported a position in COLL in Q2 2025 and has held it in 5 quarters since. The position peaked at $5.11M in Q4 2025. 279 funds tracked by Wall St. Rank hold COLL as of Q2 2026.

  • Ballast Asset Management held 112,111 shares of Collegium Pharmaceutical worth $4.06M as of Q2 2026.
  • Ballast Asset Management sold 1,112 Collegium Pharmaceutical shares in Q2 2026, an estimated $38K.
  • Collegium Pharmaceutical made up 1.62% of Ballast Asset Management's portfolio in Q2 2026, its #32 holding.
  • Ballast Asset Management first reported a position in Collegium Pharmaceutical in Q2 2025 and has held it in 5 quarters since.
  • Ballast Asset Management's Collegium Pharmaceutical position peaked at $5.11M in Q4 2025.
  • 279 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2026.

Based on Ballast Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.